AB Volvo (publ) (STO:VOLV.B)

Oncternal Therapeutics Revenue

AB Volvo had revenue of 122.90B SEK in the quarter ending June 30, 2025, a decrease of -12.37%. This brings the company's revenue in the last twelve months to 500.08B, down -9.36% year-over-year. In the year 2024, AB Volvo had annual revenue of 526.82B, down -4.61%.

• Revenue (ttm): 500.08B
• Revenue Growth: -9.36%
• P/S Ratio: 1.11
• Revenue / Employee: 5.50M
• Employees: 94,007
• Market Cap: 555.43B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	526.82B	-25.44B	-4.61%
Dec 31, 2023	552.25B	78.77B	16.64%
Dec 31, 2022	473.48B	101.26B	27.21%
Dec 31, 2021	372.22B	33.77B	9.98%
Dec 31, 2020	338.45B	-93.53B	-21.65%